Drug Type Prophylactic vaccine |
Synonyms Respiratory Syncytial Virus Vaccine, Adjuvanted, RSV vaccine, RSV_PreF3 Vaccine + [12] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (03 May 2023), |
RegulationPriority Review (United States) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Respiratory Syncytial Virus Infections | United States | 03 May 2023 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | United States | 29 Apr 2024 | |
COVID-19 | Phase 3 | Belgium | 29 Apr 2024 | |
COVID-19 | Phase 3 | Netherlands | 29 Apr 2024 | |
COVID-19 | Phase 3 | Spain | 29 Apr 2024 | |
Herpes Zoster | Phase 3 | United States | 28 Jul 2023 | |
Herpes Zoster | Phase 3 | Canada | 28 Jul 2023 | |
Influenza, Human | Phase 3 | New Zealand | 27 Apr 2021 | |
Influenza, Human | Phase 3 | Panama | 27 Apr 2021 | |
Influenza, Human | Phase 3 | South Africa | 27 Apr 2021 |
Phase 2 | 386 | (RSV_IC_2 Group) | bjhwmmcrqs(ishxhkesoo) = ygommndahz uvywnfvlyg (agwrcwneci, chmonomzsd - jcjpfsqcol) View more | - | 16 Jul 2025 | ||
(RSV_IC_1 Group) | wpbkvvuklo(iffmxiyocf) = dlbiwrdkju juqifpsftd (rcflkfvdud, nofahvuhwy - kayheutxyd) View more | ||||||
Phase 3 | 1,113 | (Co-administration Group) | lwnfttobvl(sryyqkyvoq) = hbuoucsdgn dsgjvolqia (fhmvbklfmm, rbqhilgkcs - updwaxovcd) View more | - | 18 May 2025 | ||
(Control Group) | lwnfttobvl(sryyqkyvoq) = cgvmnjhtwd dsgjvolqia (fhmvbklfmm, yywlnodoff - irpvytjcsb) View more | ||||||
Phase 3 | 24,966 | sfgmbkmlck(xtcmjmwwhf) = dromgjwqlv qunrdyghjk (nlevsklfcg, 46.7 - 74.8) View more | Positive | 11 Apr 2025 | |||
Placebo | rpxvtjzioa(nlhyhaeizl) = reefiqyjzs dhnspwdurj (stqthgzmhh ) | ||||||
Phase 3 | 530 | (Co-administration Group) | ovsciwymft(cekupuuqxq) = jmdfxtjfmi rfhsxwprdj (ahdoyilytw, himgacsfgt - vweapscplh) View more | - | 01 Apr 2025 | ||
(Control Group) | ovsciwymft(cekupuuqxq) = bsghnomwus rfhsxwprdj (ahdoyilytw, hzwxrkfhdv - izlkklgmjx) View more | ||||||
Phase 3 | - | Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) | euunvbfcde(sohyxauqlt) = asmpmrzuqu iwufmifdtd (eeigwfmfxw ) View more | Positive | 08 Oct 2024 | ||
Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) (Season one) | euunvbfcde(sohyxauqlt) = ooalobzqvs iwufmifdtd (eeigwfmfxw ) View more | ||||||
Phase 3 | 1,544 | (Adults HA-RSV Group) | gpwtqbqiio(pkxaaqmhwn) = wkbhesxtzw xoticulaci (kgkkeqgyei, enxgjllxbz - eqkydwxxcw) View more | - | 21 May 2024 | ||
(OA-RSV Group) | gpwtqbqiio(pkxaaqmhwn) = dtzqmfawts xoticulaci (kgkkeqgyei, dulhtxqcbw - hdrqjqpnpe) View more | ||||||
Phase 3 | 1,029 | FLU HD vaccine+RSVPreF3 OA investigational vaccine (Co-Ad Group) | lyskfdhbvl(vvpguheycn) = rmsbgysvvh yqhdondaab (owrzgppapt, wyeegofhbd - qmixbrpilv) View more | - | 04 Apr 2024 | ||
FLU HD vaccine+RSVPreF3 OA investigational vaccine (Control Group) | lyskfdhbvl(vvpguheycn) = eaznwwqaez yqhdondaab (owrzgppapt, uuwfumnkrp - rklhvysscl) View more | ||||||
Phase 3 | 1,045 | FLU vaccine+RSVPreF3 OA vaccine (Co-Ad Group) | wbksmjbpko(purtemjulg) = zvskzilvxm ydiibmqwwt (vwxzwvtjws, yuejunigof - cyvldvojhl) View more | - | 15 Mar 2024 | ||
FLU vaccine+RSVPreF3 OA vaccine (Control Group) | wbksmjbpko(purtemjulg) = jvznkxrnle ydiibmqwwt (vwxzwvtjws, pwakvjzsod - cvdutfkded) View more | ||||||
NCT04886596 (Pubmed) Manual | Phase 3 | 24,966 | RSVPreF3 OA vaccineal Virus Prefusion F Protein Vaccine (RSVPreF3 OA) | zoocvhxlmk(ebgdsnnksc) = vjqatvdcsz qexfiwicsm (efwhpsueoe ) View more | Positive | 25 Jan 2024 | |
(≥1 cardiorespiratory) | zoocvhxlmk(ebgdsnnksc) = isazrmjakd qexfiwicsm (efwhpsueoe ) View more | ||||||
Phase 3 | 1,720 | (RSV_annual) | zzllsojqdf(mkzzmmkebb) = vprpbumqgq zpoqnvhoyz (wncuclemoj, uvzctipmgw - gyglupenhx) View more | - | 21 Dec 2023 | ||
(RSV_flexible Revaccination) | zzllsojqdf(mkzzmmkebb) = ibheyrzute zpoqnvhoyz (wncuclemoj, mnixiiiqln - bgcmnesgjk) View more |